{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:29:53Z","timestamp":1791872993077,"version":"4.3.4"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,29]]},"DOI":"10.18632\/oncotarget.6392","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T16:21:37Z","timestamp":1448554897000},"page":"44061-44071","source":"Crossref","is-referenced-by-count":69,"title":["<i>ASXL1<\/i> mutation correction by CRISPR\/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts"],"prefix":"10.18632","volume":"6","author":[{"given":"Simona","family":"Valletta","sequence":"first","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Dolatshad","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon Ham","family":"Yip","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Bello","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanisha","family":"Gordon","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Yu","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Shaw","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swagata","family":"Roy","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scifo","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schuh","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pellagatti","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor A.","family":"Fulga","sequence":"additional","affiliation":[{"name":"Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[{"name":"Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and BRC Blood Theme, NIHR Oxford Biomedical Centre, Oxford University Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00204-015-1504-y","article-title":"Application of CRISPR\/Cas9 genome editing to the study and treatment of disease","volume":"89","author":"Boultwood","year":"2015","journal-title":"Arch Toxicol"},{"key":"3","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Zhang","year":"2013","journal-title":"Nat Protoc"},{"key":"4","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1093\/nar\/gkt464","article-title":"Chromosomal deletions and inversions mediated by TALENs and CRISPR\/Cas in zebrafish","volume":"41","author":"Zhang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Charpentier","year":"2012","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"R455","DOI":"10.1016\/S0960-9822(01)00279-2","article-title":"Non-homologous end joining as a mechanism of DNA repair","volume":"11","author":"Barnes","year":"2001","journal-title":"Curr Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Zhang","year":"2013","journal-title":"Science"},{"key":"8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Church","year":"2013","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Clevers","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Ebert","year":"2014","journal-title":"Nat Biotechnol"},{"key":"11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Li","year":"2013","journal-title":"Cell Stem Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Anderson","year":"2014","journal-title":"Nat Biotechnol"},{"key":"13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Taylor","year":"2012","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature06192","article-title":"A histone H3 lysine 27 demethylase regulates animal posterior development","volume":"449","author":"Shi","year":"2007","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Killick","year":"2010","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Chaffanet","year":"2009","journal-title":"Br J Haematol"},{"key":"17","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2010.65","article-title":"High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression","volume":"24","author":"Wainscoat","year":"2010","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases","volume":"25","author":"Haferlach","year":"2011","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","article-title":"CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia","volume":"117","author":"Hsi","year":"2011","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Levine","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2009-07-230698","article-title":"Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia","volume":"115","author":"Brock","year":"2010","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3324\/haematol.2011.045591","article-title":"Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes","volume":"96","author":"Moliterno","year":"2011","journal-title":"Haematologica"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.129","article-title":"Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression","author":"List","year":"2015","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nature13695","article-title":"Saturation editing of genomic regions by multiplex homology-directed repair","volume":"513","author":"Shendure","year":"2014","journal-title":"Nature"},{"key":"25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","article-title":"Control of developmental regulators by Polycomb in human embryonic stem cells","volume":"125","author":"Abe","year":"2006","journal-title":"Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Birnbaum","year":"2012","journal-title":"J Hematol Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Muller","year":"2010","journal-title":"Nature"},{"key":"28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/leu.2012.288","article-title":"The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics","volume":"27","author":"Dey","year":"2013","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Katavolos","year":"2012","journal-title":"Science"},{"key":"30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2014a new oral targeted therapy","volume":"346","author":"Antman","year":"2002","journal-title":"N Engl J Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stem.2014.06.011","article-title":"Whole-genome sequencing analysis reveals high specificity of CRISPR\/Cas9 and TALEN-based genome editing in human iPSCs","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"key":"32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2014.06.016","article-title":"Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones","volume":"15","author":"Soligalla","year":"2014","journal-title":"Cell Stem Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stem.2014.04.020","article-title":"Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing","volume":"15","author":"Musunuru","year":"2014","journal-title":"Cell Stem Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nbt.2652","article-title":"Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems","volume":"31","author":"Zhou","year":"2013","journal-title":"Nat Biotechnol"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2015.09.005","article-title":"Application of genome editing technologies to the study and treatment of hematological disease","author":"Boultwood","year":"2015","journal-title":"Adv Biol Regul"},{"key":"36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Jaenisch","year":"2013","journal-title":"Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biocel.2013.10.010","article-title":"One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR\/Cas9 mediated genome engineering","volume":"46","author":"Huang","year":"2014","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:38:47Z","timestamp":1589395127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":37,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015,12,29]]}},"alternative-id":["6392","26623729"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6392","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]}}}